NZ605850A - Compounds with antibacterial activity against clostridium - Google Patents
Compounds with antibacterial activity against clostridiumInfo
- Publication number
- NZ605850A NZ605850A NZ605850A NZ60585011A NZ605850A NZ 605850 A NZ605850 A NZ 605850A NZ 605850 A NZ605850 A NZ 605850A NZ 60585011 A NZ60585011 A NZ 60585011A NZ 605850 A NZ605850 A NZ 605850A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compounds
- activity against
- antibacterial activity
- against clostridium
- family
- Prior art date
Links
- 241000193403 Clostridium Species 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- PEYVWBGHBCDXRT-UHFFFAOYSA-N N1=NNC2=CN=NC2=C1 Chemical group N1=NNC2=CN=NC2=C1 PEYVWBGHBCDXRT-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical group C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10171842 | 2010-08-04 | ||
| PCT/EP2011/063434 WO2012017030A1 (en) | 2010-08-04 | 2011-08-04 | Compounds with antibacterial activity against clostridium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ605850A true NZ605850A (en) | 2014-07-25 |
Family
ID=43125618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ605850A NZ605850A (en) | 2010-08-04 | 2011-08-04 | Compounds with antibacterial activity against clostridium |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8618100B2 (enExample) |
| EP (1) | EP2601193B1 (enExample) |
| JP (1) | JP5886285B2 (enExample) |
| KR (1) | KR101499368B1 (enExample) |
| CN (1) | CN103038234B (enExample) |
| AR (1) | AR082472A1 (enExample) |
| AU (1) | AU2011287584B2 (enExample) |
| BR (1) | BR112013003675A8 (enExample) |
| CA (1) | CA2805358C (enExample) |
| CL (1) | CL2013000331A1 (enExample) |
| CO (1) | CO6680629A2 (enExample) |
| CY (1) | CY1116238T1 (enExample) |
| DK (1) | DK2601193T3 (enExample) |
| EA (1) | EA021567B1 (enExample) |
| ES (1) | ES2538998T3 (enExample) |
| HR (1) | HRP20150467T1 (enExample) |
| ME (1) | ME02061B (enExample) |
| MX (1) | MX2013001246A (enExample) |
| NZ (1) | NZ605850A (enExample) |
| PH (1) | PH12013500219A1 (enExample) |
| PL (1) | PL2601193T3 (enExample) |
| PT (1) | PT2601193E (enExample) |
| RS (1) | RS53990B1 (enExample) |
| SG (1) | SG187175A1 (enExample) |
| SI (1) | SI2601193T1 (enExample) |
| TW (1) | TWI498330B (enExample) |
| WO (1) | WO2012017030A1 (enExample) |
| ZA (1) | ZA201300432B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9079935B2 (en) | 2012-08-13 | 2015-07-14 | The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas | Reducing risk of contracting Clostridium-difficile associated disease |
| US20180000793A1 (en) * | 2015-02-06 | 2018-01-04 | Ernesto Abel-Santos | Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis |
| GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
| KR101769204B1 (ko) * | 2015-08-04 | 2017-08-17 | 씨제이헬스케어 주식회사 | 크로마놀 유도체의 신규한 제조방법 |
| US12220421B2 (en) | 2021-09-09 | 2025-02-11 | The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las | Inhibitors of C. difficile spore germination |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101652140B (zh) * | 2006-09-26 | 2013-07-10 | 克莱斯通公司 | 具有抗菌活性的对映体化合物 |
| US8658670B2 (en) * | 2006-09-26 | 2014-02-25 | Crestone, Inc. | Methods and compounds for treatment of clostridium based infection |
| WO2008039639A2 (en) | 2006-09-26 | 2008-04-03 | Crestone, Inc. | Substituted thienopyridone compounds with antibacterial activity |
-
2011
- 2011-08-03 AR ARP110102808A patent/AR082472A1/es unknown
- 2011-08-03 TW TW100127482A patent/TWI498330B/zh not_active IP Right Cessation
- 2011-08-04 PL PL11740921T patent/PL2601193T3/pl unknown
- 2011-08-04 US US13/809,238 patent/US8618100B2/en not_active Expired - Fee Related
- 2011-08-04 MX MX2013001246A patent/MX2013001246A/es not_active Application Discontinuation
- 2011-08-04 AU AU2011287584A patent/AU2011287584B2/en not_active Ceased
- 2011-08-04 NZ NZ605850A patent/NZ605850A/en not_active IP Right Cessation
- 2011-08-04 JP JP2013522249A patent/JP5886285B2/ja not_active Expired - Fee Related
- 2011-08-04 DK DK11740921.9T patent/DK2601193T3/en active
- 2011-08-04 EA EA201270817A patent/EA021567B1/ru not_active IP Right Cessation
- 2011-08-04 EP EP11740921.9A patent/EP2601193B1/en active Active
- 2011-08-04 PT PT117409219T patent/PT2601193E/pt unknown
- 2011-08-04 CA CA2805358A patent/CA2805358C/en not_active Expired - Fee Related
- 2011-08-04 RS RS20150318A patent/RS53990B1/sr unknown
- 2011-08-04 CN CN201180037487.5A patent/CN103038234B/zh not_active Expired - Fee Related
- 2011-08-04 ME MEP-2015-40A patent/ME02061B/me unknown
- 2011-08-04 PH PH1/2013/500219A patent/PH12013500219A1/en unknown
- 2011-08-04 ES ES11740921.9T patent/ES2538998T3/es active Active
- 2011-08-04 SI SI201130439T patent/SI2601193T1/sl unknown
- 2011-08-04 KR KR1020137002738A patent/KR101499368B1/ko not_active Expired - Fee Related
- 2011-08-04 BR BR112013003675A patent/BR112013003675A8/pt not_active IP Right Cessation
- 2011-08-04 WO PCT/EP2011/063434 patent/WO2012017030A1/en not_active Ceased
- 2011-08-04 SG SG2013005202A patent/SG187175A1/en unknown
- 2011-08-04 HR HRP20150467TT patent/HRP20150467T1/hr unknown
-
2013
- 2013-01-16 ZA ZA2013/00432A patent/ZA201300432B/en unknown
- 2013-02-01 CL CL2013000331A patent/CL2013000331A1/es unknown
- 2013-02-01 CO CO13019560A patent/CO6680629A2/es active IP Right Grant
-
2015
- 2015-04-30 CY CY20151100392T patent/CY1116238T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ593111A (en) | Antibacterial compounds | |
| MY149648A (en) | Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
| SG178952A1 (en) | Chemical compounds | |
| MX2010002419A (es) | (ciclopropilfenil) feniloxamidas, metodo para su produccion y uso como un medicamento. | |
| MX338114B (es) | Inhibidores de arginasa y sus aplicaciones terapeuticas. | |
| PH12014502597A1 (en) | N-substituted benzamides and their use in the treatment of pain | |
| TN2013000434A1 (en) | Novel imidazole derivatives useful for the treatment of arthritis | |
| TN2009000199A1 (en) | Heteromonocyclic compound and use thereof | |
| ECSP11010980A (es) | Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas | |
| TN2012000369A1 (en) | 5-alkynyl-pyrimidines | |
| MX340490B (es) | Derivados de pirazolo [1, 5a] pirimidina y de tieno [3, 2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4). | |
| PH12013500152A1 (en) | New aminopyrazoloquinazolines | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| TN2012000248A1 (en) | Novel spiropiperidine compounds | |
| MX2015011436A (es) | Triazolopiridinas sustituidas y metodos para usarlas. | |
| NZ704627A (en) | Spirocyclic isoxazoline parasiticidal combinations | |
| PH12014500366A1 (en) | A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes | |
| PH12013502111A1 (en) | Method for promoting plant growth | |
| BR112013024965A2 (pt) | composto, composição farmacêutica, método de tratamento de infecções virais, e, processo para preparar um composto | |
| EP3932917A3 (en) | Substituted phenyloxazolidinones for antimicrobial therapy | |
| EA201491036A1 (ru) | Производные 2-йодимидазола | |
| IN2015DN01230A (en) | Pyrrolopyrazoles as n type calcium channel blockers | |
| IN2014DN09314A (enExample) | ||
| TN2011000531A1 (en) | 5- alkynyl - pyridines | |
| EA201590350A1 (ru) | Комбинации с пептидом с циклизованной основной цепью |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 AUG 2016 BY THOMSON REUTERS Effective date: 20150711 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 AUG 2017 BY THOMSON REUTERS Effective date: 20160714 |
|
| LAPS | Patent lapsed |